AKCEA Therapeutics Canada Inc.

Platinum Sponsor

Focus: Neurology – Hereditary Transthyretin Amyloidosis (hATTR)

http://www.akceatx.ca/

Akcea Therapeutics is a drug development and commercialization company focused on advancing RNA-targeted antisense therapeutics for patients living with rare diseases including hereditary transthyretin (hATTR) amyloidosis and cardiometabolic lipid disorders including familial chylomicronemia syndrome (FCS).